Skip to main content
    N

    Nutriband Inc (NTRB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.27
    -0.05 (-0.79%)

    Market Cap: $76.82M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    32%(8/25)
    Avg Surprise
    -173.21%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jul 26
    Reported Sep 4
    		$-0.07N/AN/ABeat+96.7%
    Apr 26
    Reported Jun 11
    		$-0.08N/A+95.79%Beat+33.7%
    Jan 26
    Reported Apr 29
    		$-0.04N/A+97.88%Beat+92.2%
    Oct 25
    Reported Dec 16
    		$-0.32N/A+84.98%Beat-160.8%
    Jul 25
    Reported Sep 9
    		$-2.12$-0.17-1147.06%Miss-1274.8%
    Apr 25
    Reported May 30
    		$-0.12$-0.16+25.00%Beat+42.1%
    Jan 25
    Reported Apr 28
    		$-0.51$-0.12-325.00%Miss-122.2%
    Oct 24
    Reported Dec 3
    		$-0.12N/AN/ABeat+45.4%
    Jul 24
    Reported Sep 3
    		$-0.15$0.00N/ABeat-45.6%
    Apr 24
    Reported May 31
    		$-0.21$0.00N/ABeat-59.9%
    Jan 24
    Reported Apr 30
    		$-0.23N/AN/ABeat-35.0%
    Oct 23
    Reported Dec 12
    		$-0.22$-0.06-274.50%Miss-60.5%
    Jul 23
    Reported Sep 11
    		$-0.11$-0.07-51.29%Miss+11.8%
    Apr 23
    Reported Jun 9
    		$-0.13$-0.06-116.00%Miss-62.0%
    Jan 23
    Reported Apr 26
    		$-0.17$-0.05-240.00%Miss+63.0%
    Oct 22
    Reported Dec 2
    		$-0.14$-0.07-100.00%Miss+39.1%
    Jul 22
    Reported Sep 7
    		$-0.12$-0.07-71.43%Miss-71.4%
    Apr 22
    Reported May 31
    		$-0.08$-0.06-33.33%Miss-60.0%
    Jan 22
    Reported Apr 29
    		$-0.46$-0.09-411.11%Miss-39.4%
    Oct 21
    Reported Dec 14
    		$-0.23$-0.03-666.67%Miss-2200.0%
    Jul 21
    Reported Sep 3
    		$-0.07$0.01-800.00%Miss-133.3%
    Apr 21
    Reported Jun 14
    		$-0.05$-0.05+0.00%Beat+82.1%
    Jan 21
    Reported Apr 2
    		$-0.33$0.00N/AMiss-200.0%
    Oct 20
    Reported Dec 15
    		$-0.01N/A+66.67%Beat+80.0%
    Jul 20
    Reported Sep 11
    		$-0.03$-0.06+50.00%Beat+57.1%
    Apr 20
    Reported Jun 4
    		$-0.28$-0.11-154.55%Miss-180.0%
    Jan 20
    Reported Apr 14
    		$-0.11$-0.08-37.50%Miss-37.5%
    Oct 19
    Reported Dec 12
    		$-0.05$-0.08+37.50%Beat+28.6%
    Jul 19
    Reported Sep 13
    		$-0.07$-0.06-16.67%Miss+80.6%
    Apr 19
    Reported Jun 14
    		$-0.10$-0.07-42.86%Miss+0.0%
    Jan 19
    Reported Apr 20
    		$-0.08$0.04-300.00%Miss+80.0%
    Oct 18
    Reported Dec 14
    		$-0.07N/AN/ABeat-
    Jul 18
    Reported Sep 17
    		$-0.36N/AN/ABeat-
    Apr 18
    Reported May 1
    		$-0.10N/AN/ABeat-
    Jan 18
    Reported Jan 31
    		$-0.40N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-12.30EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-203.60%
    ROE-100.80%ROIC-101.29%
    Financial Health
    Debt/Equity0.03xInterest Coverage-338.51x
    Current Ratio4.21xQuick Ratio4.02x
    Trading Statistics
    Beta1.93Avg Volume123.04K
    52-Week High$9.1952-Week Low$2.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.58
    SMA 20$7.21
    SMA 50$5.73
    SMA 200$4.28
    EMA 10$6.58
    EMA 20$6.70
    EMA 50$5.96
    EMA 200$4.78

    MACD

    Line: 0.05Signal: 0.31Hist: -0.25

    ADX

    ADX: 32.6+DI: 17.6-DI: 16.7

    Aroon & PSAR

    Aroon Up44.0
    Aroon DownN/A
    PSAR$8.24

    Bollinger Bands

    Upper Band$8.90
    Lower Band$5.52
    %B Position4700%(Upper)
    Band Width0.22

    RSI (14-Day)

    Neutral
    47.3

    Momentum Oscillators

    Stoch %K19.5
    Stoch %D17.7
    Williams %R-82.7
    ROC (10d)-14.8%
    Momentum-1.09
    CCI (20d)-82.3
    MFI (14d)53.1

    Volatility Measures

    ATR (14d)$0.75(12.0%)
    StdDev (20d)0.85
    Hist Vol146.7%(High)

    Volume Flow

    VWAP$6.44
    OBV7.1M
    AD Line-21.5M
    CMF (20d)-0.117

    Volume Metrics

    Avg Vol (20d)128.0K
    Vol Ratio0.5x
    VWMA (20d)$7.70

    Pivot Points

    R3$6.88
    R2$6.76
    R1$6.54
    Pivot Point$6.42
    S1$6.20
    S2$6.08
    S3$5.86

    Advanced Oscillators

    TSI2.14
    Ultimate Osc36.5
    KST275.76

    Financial Data

    QuarterJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total Revenue$437,514$433,399$400,709$346,058$622,452$667,432$642,379$645,796$442,830$408,532$524,613$427,841
    Cost of Revenue$255,640$236,598$311,768$277,553$465,571$415,451$367,757$454,767$341,272$243,746$343,385$268,920
    Gross Profit$181,874$196,801$88,941$68,505$156,881$251,981$274,622$191,029$101,558$164,786$181,228$158,921
    Operating Expenses$1.07M$1.45M$1.11M$3.95M$2.16M$1.67M$2.24M$1.62M$1.51M$2.05M$1.83M$1.88M
    R&D$322,194$247,261$188,036$457,113$562,554$683,426$489,856$880,768$773,975$974,535$563,370$551,503
    SG&A$750,317$1.20M$921,820$3.49M$1.60M$982,052$1.76M$737,102$737,325$1.08M$924,207$1.33M
    Operating Income$-890,637$-1,254,351$-1,020,915$-3,880,336$-2,003,213$-1,413,497$-1,964,000$-1,426,841$-1,409,742$-1,889,477$-1,306,349$-1,723,511
    Interest Income$14,950$0$58,190$13,517$8,649$0$46,084$68,235$77,332$18$3,020$3,765
    Interest Expense$4,874$5,008$5,334$5,548$5,773$5,880$3,739$4,031$373,055$8,618$23,214$40,200
    Income Before Tax$-880,561$-1,241,956$-968,059$-3,872,367$-2,000,337$-1,388,869$-5,516,000$-1,362,637$-1,705,465$-1,898,077$-1,880,966$-1,759,946
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-880,561$-1,241,956$-968,059$-3,872,367$-2,000,337$-1,388,869$-5,516,000$-1,362,637$-1,705,465$-1,898,077$-1,880,966$-1,759,946
    EBITDA$-857,311$-1,202,771$-985,036$-3,837,280$-1,945,831$-1,325,509$-5,440,000$-1,426,841$-1,339,793$-1,820,376N/A$-1,644,179
    EBIT$-890,637$-1,236,948$-1,020,915$-3,880,336$-2,003,213$-1,382,989$-5,512,853$-1,426,841$-1,409,742$-1,889,477$-1,306,349$-1,723,511
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NTRB

    News

    Nutriband raises $1.75M from warrant exercises to fund abuse-deterrent fentanyl patch development.

    Nutriband Inc. announced it raised approximately $1.75 million through the exercise of 272,671 warrants at $6.43 each. These funds will be allocated towards the clinical development and FDA submission of AVERSA Fentanyl...

    Pluang•10/13/26•Bullish

    Nutriband (NTRB) Raises $1.75M from Warrant Exercise to Fund AVERSA Fentanyl Development

    Nutriband Inc. (NTRB) has raised $1.75 million through warrant exercises to fund the clinical development and FDA submission of its AVERSA abuse-deterrent fentanyl patch. Despite this capital infusion and strong...

    GuruFocus•10/13/26•Neutral

    Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274

    Nutriband Inc. announced the exercise of 272,671 NTRBW warrants at a strike price of $6.43, generating gross proceeds of $1,753,274.53. These proceeds will primarily fund the remaining clinical development of AVERSA...

    Yahoo Finance•10/13/26•Bullish

    Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274

    Nutriband Inc. (NASDAQ:NTRB) announced the exercise of 272,671 NTRBW warrants at a strike price of $6.43, generating gross proceeds of $1,753,274.53. These proceeds will primarily fund the remaining clinical development...

    GlobeNewswire•10/13/26•Bullish

    Nutriband files patent application for abuse-deterrent patch technology By Investing.com

    Nutriband Inc. has filed a non-provisional utility patent application for its AVERSA abuse-deterrent transdermal technology...

    Investing.com Canada•10/9/26•Bullish

    NTRB Valuation and Fair Value

    P/E
    -12.3x
    Forward P/E
    370.4x
    P/B
    14.3x
    See GNG's fair value

    NTRB Profitability: Margins, ROIC and FCF

    Gross margin
    33.1%
    Operating margin
    -203.6%
    Net margin
    0.0%
    ROIC
    -101.3%
    ROE
    -100.8%
    FCF margin
    -224.9%

    NTRB Competitors

    CompanyTicker
    Telomir Pharmaceuticals, Inc. Common StockTELO
    NeOnc Technologies Holdings, Inc. Common StockNTHI
    Pelthos Therapeutics Inc.PTHS
    Cognition Therapeutics IncCGTX
    Kazia Therapeutics Ltd ADRKZIA
    Electrocore LLCECOR
    Lixte Biotechnology Holdings IncLIXT
    InterCure Ltd.INCR

    Sector: Healthcare

    NTRB Bull Case vs Bear Case

    Bear case

    • NTRB's quarterly revenue changed -29.7% year over year.

    NTRB Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -194.7%

    Frequently Asked Questions About NTRB

    Does NTRB pay dividends?

    Nutriband Inc (NTRB) does not currently pay a regular dividend.

    What is NTRB's market cap?

    Nutriband Inc (NTRB) has a market capitalization of $76.82M with a current stock price of $6.27.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In